Wenkai Zou
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Complement C4 exacerbates astrocyte-mediated neuroinflammation and promotes α-synuclein pathology in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: February 09, 2025
TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.
TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.
Journal: International immunopharmacology
Published: July 31, 2024
Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson's disease.
Journal: Brain, behavior, and immunity
Published: June 17, 2024
Mitochondria-lysosome-extracellular vesicles axis and nanotheranostics in neurodegenerative diseases.
Journal: Experimental neurology
Published: December 21, 2023
Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease.
Journal: Ageing research reviews
Published: July 17, 2023
Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
Journal: CNS neuroscience & therapeutics
Published: May 07, 2023
Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
Journal: Neurobiology of disease
Published: May 03, 2023
Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis.
Journal: CNS neuroscience & therapeutics
Published: May 16, 2022
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Journal: Journal of neuroinflammation
Published: November 20, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026